Trump touts drugmaker deals offering cheaper medicines to state Medicaid programs

The Trump administration is promoting the GENEROUS program, under which pharmaceutical companies would provide discounted drugs to state Medicaid programs, with the president touting participation by every state. Administration officials are presenting the deals as a win for lowering prescription drug costs through Medicaid, but many details of how the discounts will work, their size, and their impact on state budgets remain unknown.